Walker & Dunlop, Inc.

Walker & Dunlop, Inc. (NYSE:WD) shares are trading lower after Wedbush analyst Jay McCanless downgraded the stock to Neutral from Outperform and cut the price target to $95 (from $130). The analyst’s re-rating reflects the expectation that a higher for longer rate environment will again put pressure on transaction volumes this year. The analyst says that the rate of volatility is showing no signs of easing and fears that the consistent rate of volatility seen thus far through ...Full story available on Benzinga.com

Related tickers: WD.

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. Fastenal reported first-quarter FY24 sales growth of 1.9% Y/Y to $1.895 billion, missing the consensus of $1.914 billion. The company's first-quarter EPS was 52 cents, missing the consensus of 53 cents. Fastenal shares dipped 6.7% to $69.73 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Rallybio Corporation (NASDAQ: RLYB) shares climbed 89.6% to $3.09 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT. Rent the Runway, Inc. (NASDAQ: RENT) shares jumped 74.5% to $12.91 after the company reported mixed fourth-quarter financial results and issued guidance. Eliem Therapeutics, Inc. (NASDAQ: ELYM) jumped 59.6% to $4.2650. The company announced that it entered into a definitive acquisition agreement to acquire Tenet and it also entered into a securities purchase agreement for a $120 million private placement. Akanda Corp. (NASDAQ: AKAN) gained 36% to $0.1632. Akanda, last month, announced a plan to evaluate opportunities in Bitcoin, Blockchain and AI applications in the cannabis industry. Alpine Immune Sciences, Inc. (NASDAQ: ALPN) rose 36.6% to $64.25 after Vertex entered into an agreement to acquire the company. Candel Therapeutics, Inc. (NASDAQ: CADL) surged 29.6% to $6.61 after the company received FDA orphan drug designation for CAN-2409 for the treatment of pancreatic cancer. Enliven Therapeutics, Inc. (NASDAQ: ELVN) gained 26% to $24.97. Enliven Therapeutics announced proof ...

Related tickers: APVO, ELYM, GL, SPRC, ICCT, AKAN, ACOR, LOVE, SLNA, CLRO, VERB, GVH, FAST, ENLV, GYRE, RENT, JFU, SUUN, KMX, RCEL, WD, AIH, ELVN, NKLA, ALPN, STEP, NRIX, MRIN, WNW, ESPR, JANX, VBIV, NYXH, GCT, CADL, ANAB, RLYB.